Cuesta R R - OmicsDI

Show results for

Unknown (515)
Genomics (16)
Proteomics (10)
Transcriptomics (8)
Metabolomics (1)

Organisms

Homo sapiens (26)
Mus musculus (3)
Leishmania major (1)
Escherichia coli str. K-12 substr. MG1655 (1)
Arabidopsis thaliana (1)
Bos taurus (1)
Formica sp. BOLD:AAA1469 (1)
Fructilactobacillus sanfranciscensis DSM 20451 (1)
Lactobacillus delbrueckii subsp. bulgaricus CNCM I-1632 (1)
Oecophyllibacter saccharovorans (1)
Streptococcus thermophilus MTCC 5460 (1)
Wolbachia endosymbiont of Schlechtendalia chinensis (1)
Xenopus laevis (1)

Repository

EGA (14)
biostudies-arrayexpress (10)
pride (10)
MetaboLights (1)

Tissue

Cell culture (5)
Colon epithelial cell (2)
B cell (1)
Bone marrow (1)
MCF-7 cell (1)
Macrophage (1)
Oocyte (1)
Plant cell (1)
Root (1)
Seedling (1)

Disease

Colon cancer (2)
Breast cancer (1)
Inflammation (1)

Technology Type

Mass Spectrometry (10)
Shotgun proteomics (5)
Affinity purification coupled with mass spectrometry proteomics (2)
Bottom-up proteomics (2)
Illumina HiSeq 2000, Affymetrics_SNP_6.0- (1)
Illumina HiSeq 2000, Affymetrics_SNP_6.0-, Illumina Genome Analyzer IIx (1)
Illumina HiSeq 2000, Affymetrix SNP 6.0 (1)
Mass spectrometry assay (1)
Data-independent acquisition (1)
Gel-based experiment (1)

Instrument Platform

NextSeq 500 (3)
MoFlo Legacy cell sorter (Beckman Coulter) (1)
PC (1)
Illumina NovaSeq 6000 (1)
Liquid Chromatography MS - alternating - reverse phase (1)

Publication Date

2026 (3)
2020 (3)
2019 (3)
2010 (3)
2023 (3)
2025 (2)
2018 (1)
2013 (1)
2011 (1)
2024 (1)

CHEBI ID

CHEBI134216 (1)
CHEBI15354 (1)
CHEBI15544 (1)
CHEBI15558 (1)
CHEBI15603 (1)
CHEBI15614 (1)
CHEBI15676 (1)
CHEBI15698 (1)
CHEBI15724 (1)
CHEBI15728 (1)
CHEBI15741 (1)
CHEBI16020 (1)
CHEBI16220 (1)
CHEBI16259 (1)
CHEBI16318 (1)
CHEBI16344 (1)
CHEBI16347 (1)
CHEBI16349 (1)
CHEBI16359 (1)
CHEBI16411 (1)
CHEBI16414 (1)
CHEBI16437 (1)
CHEBI16450 (1)
CHEBI16467 (1)
CHEBI16534 (1)
CHEBI16543 (1)
CHEBI16610 (1)
CHEBI16643 (1)
CHEBI16704 (1)
CHEBI16737 (1)

Metabolite Name

1-Aminocyclopropanecarboxylic acid (1)
1-Methyladenosine (1)
15(S)-HETE (1)
2,6-Dihydroxybenzoic acid (1)
2-Hydroxy-3-methylbutyric acid (1)
2-Hydroxycaproic acid (1)
2-Methylhippuric acid (1)
2-Oxoglutaric acid (1)
3-Hydroxybutyric acid (1)
3-Hydroxyphenylacetic acid (1)
3-Hydroxyproline (1)
3-Indoxylsulfuric acid (1)
3-Methyl-2-oxovaleric acid (1)
3-Ureidopropionic acid (1)
4,6-Dioxoheptanoic acid (1)
4-Guanidinobutyric acid (1)
4-Hydroxybenzaldehyde (1)
4-Hydroxyhippuric acid (1)
4-Nitrocatechol (1)
4-pyridoxic acid (1)
5-Aminolevulinic acid (1)
5-Hydroxyferulic acid (1)
5-Methylcytidine (1)
5-O-Caffeoylshikimic acid (1)
7-Methylguanine (1)
?-Hydroxyisovaleric acid (1)
?-Muricholic acid (1)
ADP (1)
Acetylcarnitine (1)
Aconitic acid (1)

Study type

Transcription profiling by array (4)
Comparative genomic hybridization by array (2)
DNA-seq (2)
Spatial transcriptomics by high-throughput sequencing (1)
Bisulfite-seq (1)

Release Date

2021 (78)
2022 (73)
2023 (61)
2020 (56)
2025 (52)
2024 (48)
2019 (33)
2018 (30)
2016 (17)
2015 (14)
2017 (12)
2012 (9)
2026 (8)
2010 (8)
2014 (8)
2013 (6)
2011 (4)
2009 (3)
2008 (2)
2004 (1)
2001 (1)
1999 (1)

Lab affiliation

Senior Director, Dynamic Omics, CGR, One Medimmune Way Gaithersburg, MD 20878 (2)
Chromosomal Replication Laboratory, Institute for Cancer and Genomic Sciences, IBR west, WX2.62, University of Birmingham, Edgbaston, Birmingham, B15 2TT (1)
Department of Microbial Sciences School of Biosciences and Medicine University of Surrey (1)
Discovery Biology, AstraZeneca Pharmaceuticals (1)
Institute of Science and Technology, Austria, Klosterneuburg. (1)
Mass Spectrometry Facility Barts Cancer Institute Lab 1.01 1st floor Queen Mary, University of London John Vane Science Centre, Charterhouse Square, London EC1M 6BQ (1)
New York Medical College (1)
Novo Nordisk Foundation Center for Biosustainability, DTU Biosustain, Kgs. Lyngby, Denmark (1)
Paul J Lehner PhD FRCP FMed Sci FRS Sheila Joan Smith Professor of Immunology Wellcome Principal Fellow and Honorary Consultant University of Cambridge CITIID Cambridge Biomedical Campus Cambridge CB2 0AW (1)

Previous page
1 / 55
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 55
Next page

Sort by:

Relevance

Page size

Transcatheter aortic valve replacement using the new Evolut-Pro system: a prospective comparison with the Evolut-R device.

Not available

S-EPMC8339791 | biostudies-literature

A TRIM21-based bioPROTAC highlights the therapeutic benefit of HuR degradation.

Not available

S-EPMC10625600 | biostudies-literature

Mechanisms Considering Public Investment in Pricing and Reimbursement Decisions of Medicines and Other Health Technologies: A Scoping Review.

Not available

S-EPMC12790488 | biostudies-literature

The relationship between maladaptive appraisals and posttraumatic stress disorder: a meta-analysis.

Not available

S-EPMC6566671 | biostudies-literature

Targeted protein degradation using chimeric human E2 ubiquitin-conjugating enzymes.

Not available

S-EPMC11415077 | biostudies-literature

Early-life stress and the gut microbiome: A comprehensive population-based investigation.

Not available

S-EPMC7615798 | biostudies-literature

Targeted protein degradation using E2 ubiquitin-conjugating enzymes

Proteins can be targeted for degradation by using engineered molecular conjugates to enhance their interaction with eukaryotic ubiquitination machinery. For instance, the fusion of an E3 ubiquitin ligase to a suitable target binding domain creates a biological ‘Proteolysis-Targeting Chimera’ (bioPRO...

ORGANISM(S): Homo sapiens (Human)

2024-09-23 | PXD041225 | Pride

Bioprotac